Ahmet Mesrur Halefoğlu

Multiple cranial nerve schwannomas and meningiomas as a hallmark sign of neurofibromatosis type 2 in a child

Neurofibromatosis type 2 is a rarely encountered autosomal dominantdisorder manifesting with typical radiological findings. These patients have apredilection for development of benign tumors in the central nervous system.Although the presenting symptom is most commonly hearing loss due toacoustic schwannomas, symptoms emanating from other cranial tumors are notuncommon. Herein, we described a 16-year-old male patient presented withmultiple meningiomas and cranial nerve schwannomas revealed by magneticresonance imaging. He fulfilled the diagnostic criteria of neurofibromatosistype 2 and underwent treatment. We emphasized the role of radiology in theearly diagnosis of this inherited disorder in order to provide a better prognosis.

PDF

___

1. Asthagiri AR, Parry DM, Butman JA, et al. Neurofibromatosis type 2. Lancet 2009; 373: 1974- 1986.
2. Mautner VF, Baser ME, Thakkar SD, Feigen UM, Freidman JM, Kluwe L. Vestibular schwannoma growth in patients with neurofibromatosis type 2: A longitudinal study. J Neurosurg 2002; 96: 223-228.
3. Janse AJ, Tan WF, Majoie ChBLM, Bijlsma EK. Neurofibromatosis type 2 diagnosed in the absence of vestibular schwannomas. A case report and guidelines for a screening protocol for children at risk. Eur J Pediatr 2001; 160: 439-443.
4. Rouleau GA, Wertelecki W, Haines JL, et al. Genetic linkage of bilateral acoustic neurofibromatosis to a DNA marker on chromosome 22. Nature 1987; 329: 246-248.
5. Egelhoff JC, Bates DJ, Ross JS, Rothner AD, Cohen BH. Spinal MR findings in neurofibromatosis types 1 and 2. AJNR Am J Neuroradiol 1992; 13: 1071-1077.
6. Mautner VF, Tatagiba M, Lindenau M, et al. Spinal tumors in patients with neurofibromatosis type 2: MR imaging study of frequency, multiplicity and variety. AJR Am J Roentgenol 1995; 165: 951-955.
7. Moffat DA, Quaranta N, Baguley DM, Hardy DG, Chang P. Management strategies in neurofibromatosis type 2. Eur Arch Otohinolaryngol 2003; 260: 12-18.
8. Gutmann DH, Aylsworth A, Carey JC, et al. The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2. JAMA 1997; 278: 51-57.
9. Evans DG, Mason S, Huson SM, Ponder M, Harding AE, Strachan T. Spinal and cutaneous schwannomatosis is a variant form of type 2 neurofibromatosis: a clinical and molecular study. J Neurol Neurosurg Psychiatry 1997; 62: 361-366.
10. Evans DG, Huson SM, Donnai D, et al. A clinical study of type 2 neurofibromatosis. Q J Med 1992; 84: 603-618.
11. Ragge NK, Baser ME, Klein J, et al. Ocular abnormalities in neurofibromatosis 2. Am J Ophtalmol 1995; 120: 634-641.
12. Bouzas EA, Parry DM, Eldridge R, Kaiser-Kupfer MI. Visual impairment in patients with neurofibromatosis 2. Neurology 1993; 43: 622-623.
13. Russell DS, Rubinstein LJ. Tumors of the cranial, spinal peripheral nerve sheaths. In: Russell DS, Rubinstein LJ (eds). Pathology of the Tumours of the Nervous System (5th ed). London: Edward Arnold; 1989: 533- 589.
14. Mautner VF, Lindenau M, Baser ME, et al. The neuroimaging and clinical spectrum of neurofibromatosis 2. Neurosurgery 1996; 38: 880-885.
15. Mautner VF, Tatagiba M, Laute S, Guthoff R, Samii M, Pulst SM. Clinical and genetic analysis of neurofibromatosis type 2 (abstr). Neurology 1992; 42(Suppl 3): 473.
16. Wayman JW, Dutcher PO Jr, Manzione JV, Nelson CN, Kido DK. Gadolinium-DTPA-enhanced magnetic resonance scanning in cerebellopontine angle tumors. Laryngoscope 1989; 99: 1167-1170.
17. Nunes F, MacCollin M. Neurofibromatosis 2 in the pediatric population. J Child Neurol 2003; 18: 718-724.
18. Bosch MM, Boltshauser E, Harpes P, Landau K. Ophtalmogic findings and long- term course in patients with neurofibromatosis type 2. Am J Ophtalmol 2006; 141: 1068-1077.
19. Ruggieri M, Iannetti P, Polizzi A, et al. Earliest clinical manifestations and natural history of neurofibromatosis type 2 (NF2) in childhood: a study of 24 patients. Neuropediatrics 2005; 36: 21-34.
20. Perry A, Giannini C, Raghawan R, et al. Aggressive phenotypic and genotypic features in pediatric and NF2-associated meningomas: a clinicopathologic study of 53 cases. J Neuropathol Exp Neurol 2001; 60: 994- 1003.